Research ArticleHuman Study
Radioimmunotherapy of Medullary Thyroid Cancer with Iodine-131-Labeled Anti-CEA Antibodies
Malik Juweid, Robert M. Sharkey, Thomas Behr, Lawrence C. Swayne, Thomas Herskovic, Michael Pereira, Arnold D. Rubin, Debra Hanley, Robert Dunn, Jeffry Siegel and David M. Goldenberg
Journal of Nuclear Medicine June 1996, 37 (6) 905-911;
Malik Juweid
Robert M. Sharkey
Thomas Behr
Lawrence C. Swayne
Thomas Herskovic
Michael Pereira
Arnold D. Rubin
Debra Hanley
Robert Dunn
Jeffry Siegel


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Radioimmunotherapy of Medullary Thyroid Cancer with Iodine-131-Labeled Anti-CEA Antibodies
Malik Juweid, Robert M. Sharkey, Thomas Behr, Lawrence C. Swayne, Thomas Herskovic, Michael Pereira, Arnold D. Rubin, Debra Hanley, Robert Dunn, Jeffry Siegel, David M. Goldenberg
Journal of Nuclear Medicine Jun 1996, 37 (6) 905-911;
Radioimmunotherapy of Medullary Thyroid Cancer with Iodine-131-Labeled Anti-CEA Antibodies
Malik Juweid, Robert M. Sharkey, Thomas Behr, Lawrence C. Swayne, Thomas Herskovic, Michael Pereira, Arnold D. Rubin, Debra Hanley, Robert Dunn, Jeffry Siegel, David M. Goldenberg
Journal of Nuclear Medicine Jun 1996, 37 (6) 905-911;
Jump to section
Related Articles
- No related articles found.
Cited By...
- SPECT- and Fluorescence Image-Guided Surgery Using a Dual-Labeled Carcinoembryonic Antigen-Targeting Antibody
- Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement
- A transplantable human medullary thyroid carcinoma as a model for RET tyrosine kinase-driven tumorigenesis
- Enhanced Antitumor Activity of Combined Pretargeted Radioimmunotherapy and Paclitaxel in Medullary Thyroid Cancer Xenograft
- A Phase I Radioimmunotherapy Trial Evaluating 90Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies
- Successful Surgical Removal of Occult Metastases of Medullary Thyroid Carcinoma Recurrences with the Help of Immunoscintigraphy and Radioimmunoguided Surgery